FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012073192> ?p ?o ?g. }

• W2012073192 endingPage "1036" @default.
• W2012073192 startingPage "1028" @default.
• W2012073192 abstract "Purpose: To study RhoA activation and the effect of the Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy (OIR).Methods: C57BL/6 mice at postnatal day (P7) were exposed to hyper-oxygen for 5 days and returned to room air for 5 days to induce OIR. RhoA-GTP, an active form of RhoA, in retinas at P12, P13 and P17 was detected. Mice received a single intravitreal injection of Y27632 (5 µM or 50 µM), a Rho-kinase inhibitor, in one eye during the transition from oxygen to room air at P12. Contralateral eyes were used as the control. Fluorescein-conjugated dextran angiography of retinal whole mount was prepared to score features of neovascular retinopathy at P17. The preretinal neovascular nuclei quantification was performed in frozen sections as well to evaluate the neovascularization.Results: The retinal RhoA-GTP in OIR mice significantly increased from 0.24 ± 0.06 at P12 to 0.38 ± 0.12 at P13 (p < 0.05). The median total retinopathy score of 5.7 was significantly lower in eyes treated with Y27632 than controls (p < 0.001). Significant improvement was found in the specific categories of vascular tufts (p < 0.01) and extraretinal neovascularization (p < 0.05) in treated eyes. Those treated eyes also had a significantly decreased number of neovascular nuclei (p < 0.01).Conclusions: These results suggest that Rho/Rho-kinase signaling pathways are involved in the early process of hypoxia-induced retinal neovascularization and Y27632 might have therapeutic potential for the treatment of retinal neovascularization." @default.
• W2012073192 created "2016-06-24" @default.
• W2012073192 creator A5069584678 @default.
• W2012073192 creator A5071301207 @default.
• W2012073192 creator A5076608744 @default.
• W2012073192 creator A5078752214 @default.
• W2012073192 date "2011-10-14" @default.
• W2012073192 modified "2023-09-26" @default.
• W2012073192 title "RhoA Activation and Effect of Rho-kinase Inhibitor in the Development of Retinal Neovascularization in a Mouse Model of Oxygen-induced Retinopathy" @default.
• W2012073192 cites W1597787921 @default.
• W2012073192 cites W1802218256 @default.
• W2012073192 cites W1839381104 @default.
• W2012073192 cites W1967004211 @default.
• W2012073192 cites W1987677893 @default.
• W2012073192 cites W1987973305 @default.
• W2012073192 cites W1988862154 @default.
• W2012073192 cites W2000292756 @default.
• W2012073192 cites W2009091430 @default.
• W2012073192 cites W2014789648 @default.
• W2012073192 cites W2019731805 @default.
• W2012073192 cites W2024904424 @default.
• W2012073192 cites W2029421992 @default.
• W2012073192 cites W2035412062 @default.
• W2012073192 cites W2052608599 @default.
• W2012073192 cites W2053938092 @default.
• W2012073192 cites W2055935186 @default.
• W2012073192 cites W2066926102 @default.
• W2012073192 cites W2072743356 @default.
• W2012073192 cites W2077603983 @default.
• W2012073192 cites W2088255586 @default.
• W2012073192 cites W2093045792 @default.
• W2012073192 cites W2096791952 @default.
• W2012073192 cites W2100837885 @default.
• W2012073192 cites W2107604105 @default.
• W2012073192 cites W2111807830 @default.
• W2012073192 cites W2112451265 @default.
• W2012073192 cites W2117968545 @default.
• W2012073192 cites W2118188473 @default.
• W2012073192 cites W2123910376 @default.
• W2012073192 cites W2138507504 @default.
• W2012073192 cites W2141197297 @default.
• W2012073192 cites W2146587653 @default.
• W2012073192 cites W2162371883 @default.
• W2012073192 cites W2164923772 @default.
• W2012073192 cites W2169821500 @default.
• W2012073192 cites W2169949219 @default.
• W2012073192 cites W2375169070 @default.
• W2012073192 cites W4235333461 @default.
• W2012073192 cites W4297403177 @default.
• W2012073192 doi "https://doi.org/10.3109/02713683.2011.593110" @default.
• W2012073192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21999228" @default.
• W2012073192 hasPublicationYear "2011" @default.
• W2012073192 type Work @default.
• W2012073192 sameAs 2012073192 @default.
• W2012073192 citedByCount "10" @default.
• W2012073192 countsByYear W20120731922013 @default.
• W2012073192 countsByYear W20120731922015 @default.
• W2012073192 countsByYear W20120731922016 @default.
• W2012073192 countsByYear W20120731922017 @default.
• W2012073192 countsByYear W20120731922019 @default.
• W2012073192 countsByYear W20120731922021 @default.
• W2012073192 countsByYear W20120731922022 @default.
• W2012073192 crossrefType "journal-article" @default.
• W2012073192 hasAuthorship W2012073192A5069584678 @default.
• W2012073192 hasAuthorship W2012073192A5071301207 @default.
• W2012073192 hasAuthorship W2012073192A5076608744 @default.
• W2012073192 hasAuthorship W2012073192A5078752214 @default.
• W2012073192 hasConcept C118487528 @default.
• W2012073192 hasConcept C134018914 @default.
• W2012073192 hasConcept C184235292 @default.
• W2012073192 hasConcept C185592680 @default.
• W2012073192 hasConcept C201800478 @default.
• W2012073192 hasConcept C2777093181 @default.
• W2012073192 hasConcept C2778271429 @default.
• W2012073192 hasConcept C2778313320 @default.
• W2012073192 hasConcept C2780394083 @default.
• W2012073192 hasConcept C2780827179 @default.
• W2012073192 hasConcept C502942594 @default.
• W2012073192 hasConcept C55493867 @default.
• W2012073192 hasConcept C555293320 @default.
• W2012073192 hasConcept C62478195 @default.
• W2012073192 hasConcept C71924100 @default.
• W2012073192 hasConceptScore W2012073192C118487528 @default.
• W2012073192 hasConceptScore W2012073192C134018914 @default.
• W2012073192 hasConceptScore W2012073192C184235292 @default.
• W2012073192 hasConceptScore W2012073192C185592680 @default.
• W2012073192 hasConceptScore W2012073192C201800478 @default.
• W2012073192 hasConceptScore W2012073192C2777093181 @default.
• W2012073192 hasConceptScore W2012073192C2778271429 @default.
• W2012073192 hasConceptScore W2012073192C2778313320 @default.
• W2012073192 hasConceptScore W2012073192C2780394083 @default.
• W2012073192 hasConceptScore W2012073192C2780827179 @default.
• W2012073192 hasConceptScore W2012073192C502942594 @default.
• W2012073192 hasConceptScore W2012073192C55493867 @default.
• W2012073192 hasConceptScore W2012073192C555293320 @default.
• W2012073192 hasConceptScore W2012073192C62478195 @default.
• W2012073192 hasConceptScore W2012073192C71924100 @default.
• W2012073192 hasIssue "11" @default.

• next